wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38128723-65479AE6-D2AA-4FD3-8134-EEA0D5C65162
Q38128723-65479AE6-D2AA-4FD3-8134-EEA0D5C65162
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38128723-65479AE6-D2AA-4FD3-8134-EEA0D5C65162
The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients.
P2860
Q38128723-65479AE6-D2AA-4FD3-8134-EEA0D5C65162
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38128723-65479AE6-D2AA-4FD3-8134-EEA0D5C65162
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
76e671189a8103494b0572666a849a6d6439a6bc
P2860
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer.